Anti-alpha-V-beta-3 G4 antibody (Alpha Beta Therapeutics)

N/A

Report date: 2024/04/24 17:47:31

Base Information

Drug NameAnti-alpha-V-beta-3 G4 antibody (Alpha Beta Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionIntegrin alpha-V/beta-3 antagonists
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlpha Beta Therapeutics AB
China Registration ClassN/A

Develop Information

Active CompaniesAlpha Beta Therapeutics AB
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A